Century Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Century Therapeutics Depreciation & Amortization Growth & History (IPSC)
Century Therapeutics's depreciation and amortization was $13.1M for fiscal 2025.
View full Century Therapeutics company overviewCentury Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13.1M | −$203,000 | −1.53% |
| 2024 | 2024-12-31 | $13.3M | $260,000 | +1.99% |
| 2023 | 2023-12-31 | $13.0M | $4.6M | +54.55% |
| 2022 | 2022-12-31 | $8.4M | $4.7M | +125.19% |
| 2021 | 2021-12-31 | $3.7M | $2.3M | +167.33% |
| 2020 | 2020-12-31 | $1.4M | — | — |
Century Therapeutics quarterly depreciation and amortization
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $26,000 | −$3.2M | −99.19% |
| Q1 2026 | 2026-03-31 | $3.0M | −$217,000 | −6.74% |
| Q4 2025 | 2025-12-31 | $3.5M | — | — |
| Q3 2025 | 2025-09-30 | $3.1M | −$168,000 | −5.10% |
| Q2 2025 | 2025-06-30 | $3.2M | −$261,000 | −7.54% |
| Q1 2025 | 2025-03-31 | $3.2M | −$5,000 | −0.15% |
| Q3 2024 | 2024-09-30 | $3.3M | −$53,000 | −1.58% |
| Q2 2024 | 2024-06-30 | $3.5M | $228,000 | +7.05% |
| Q1 2024 | 2024-03-31 | $3.2M | $318,000 | +10.94% |
| Q3 2023 | 2023-09-30 | $3.4M | $576,000 | +20.76% |
| Q2 2023 | 2023-06-30 | $3.2M | $1.6M | +93.88% |
| Q1 2023 | 2023-03-31 | $2.9M | $1.7M | +150.69% |
| Q3 2022 | 2022-09-30 | $2.8M | $1.7M | +165.71% |
| Q2 2022 | 2022-06-30 | $1.7M | $733,000 | +78.40% |
| Q1 2022 | 2022-03-31 | $1.2M | $442,000 | +61.56% |
| Q3 2021 | 2021-09-30 | $1.0M | $634,000 | +154.63% |
| Q2 2021 | 2021-06-30 | $935,000 | $653,000 | +231.56% |
| Q1 2021 | 2021-03-31 | $718,000 | — | — |
| Q3 2020 | 2020-09-30 | $410,000 | — | — |
| Q2 2020 | 2020-06-30 | $282,000 | — | — |
Century Therapeutics depreciation and amortization trends
Over the last five fiscal years, Century Therapeutics's depreciation and amortization increased from $1.4M to $13.1M, a change of $11.7M. The latest reported quarter, Q2 2026, shows $26,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Century Therapeutics source filings ↗